Diagnostic criteria of acute liver failure: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan

被引:97
|
作者
Mochida, Satoshi [2 ]
Takikawa, Yasuhiro [3 ]
Nakayama, Nobuaki [2 ]
Oketani, Makoto [1 ]
Naiki, Takafumi [4 ]
Yamagishi, Yoshiyuki [5 ]
Ichida, Takafumi [6 ]
Tsubouchi, Hirohito [1 ]
机构
[1] Kagoshima Univ, Hlth Res Course, Dept Digest & Life Style Related Dis, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan
[2] Saitama Med Univ, Dept Gastroenterol & Hepatol, Moroyama, Saitama, Japan
[3] Iwate Med Univ, Sch Med, Dept Gastroenterol & Hepatol, Morioka, Iwate 020, Japan
[4] Gifu Univ, Grad Sch Med, Dept Gastroenterol, Gifu, Japan
[5] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan
[6] Juntendo Univ, Shizuoka Hosp, Dept Gastroenterol, Izunokuni, Japan
关键词
acute liver failure; diagnostic criteria; fulminant hepatitis; hepatic encephalopathy; late onset hepatic failure; ONSET HEPATIC-FAILURE; FULMINANT-HEPATITIS;
D O I
10.1111/j.1872-034X.2011.00860.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The diagnostic criteria of fulminant hepatitis in Japan are different from those of acute liver failure in Europe and the United States, both in regard to the histological features in the liver and the cutoff values of the prothrombin time. Thus, the Intractable Hepato-Biliary Disease Study Group established novel diagnostic criteria for "acute liver failure" in Japan based on the demographic and clinical features of the patients. Patients showing prothrombin time values of 40% or less of the standardized values or international normalized ratios of 1.5 or more caused by severe liver damage within 8 weeks of onset of the symptoms are diagnosed as having "acute liver failure", where the liver function prior to the current onset of liver damage is estimated to be normal. Acute liver failure is classified into "acute liver failure without hepatic coma" and "acute liver failure with hepatic coma," depending on the severity of the hepatic encephalopathy; the latter is further classified into two types, the "acute type" and the "subacute type", in which grade II or more severe hepatic coma develops within 10 days and between 11 and 56 days, respectively, after the onset of disease symptoms. Patients without histological findings of hepatitis, such as those with liver damage caused by drug toxicity, circulatory disturbance or metabolic disease, are also included in the disease entity of "acute liver failure", while acute-on-chronic liver injuries, such as liver injury caused by alcohol, are excluded. A nationwide survey of "acute liver failure" in Japan based on the novel criteria is proposed.
引用
收藏
页码:805 / 812
页数:8
相关论文
共 50 条
  • [1] Classification of the etiologies of acute liver failure in Japan: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan
    Mochida, Satoshi
    Takikawa, Yasuhiro
    Nakayama, Nobuaki
    Oketani, Makoto
    Naiki, Takafumi
    Yamagishi, Yoshiyuki
    Fujiwara, Keiichi
    Ichida, Takafumi
    Tsubouchi, Hirohito
    HEPATOLOGY RESEARCH, 2014, 44 (04) : 365 - 367
  • [2] Revised criteria for classification of the etiologies of acute liver failure and late-onset hepatic failure in Japan: A report by the Intractable Hepato-biliary Diseases Study Group of Japan in 2015
    Mochida, Satoshi
    Nakayama, Nobuaki
    Ido, Akio
    Takikawa, Yasuhiro
    Yokosuka, Osamu
    Sakaida, Isao
    Moriwaki, Hisataka
    Genda, Takuya
    Takikawa, Hajime
    HEPATOLOGY RESEARCH, 2016, 46 (05) : 369 - 371
  • [3] Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol
    Liu, JP
    Kjaergard, LL
    Als-Nielsen, B
    Gluud, C
    LIVER, 2002, 22 (05): : 433 - 438
  • [4] Meta-analysis: antioxidant supplements for liver diseases - the Cochrane Hepato-Biliary Group
    Bjelakovic, G.
    Gluud, L. L.
    Nikolova, D.
    Bjelakovic, M.
    Nagorni, A.
    Gluud, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (03) : 356 - 367
  • [5] THE DIAGNOSTIC SIGNIFICANCE OF ELECTROPHORETIC SERUM PROTEIN FRACTIONS IN HEPATO-BILIARY DISEASES
    TSUMAGARI, Y
    POPPER, H
    BEAN, WB
    FRANKLIN, M
    ROUTH, JI
    DELAHUERGA, J
    STEIGMANN, F
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1950, 36 (06): : 999 - 1000
  • [6] POLYCYSTIC LIVER-DISEASE - HEPATO-BILIARY SEQUENTIAL SCINTIGRAPHY IN COMPARISON WITH OTHER DIAGNOSTIC PROCEDURES
    REICHELT, HG
    RADIOLOGE, 1977, 17 (09): : 396 - 400
  • [7] VITAMIN D SUPPLEMENTATION FOR CHRONIC LIVER DISEASE - A COCHRANE HEPATO-BILIARY GROUP SYSTEMATIC REVIEW
    Bjelakovic, G.
    Nikolova, D.
    Bjelakovic, M.
    Gluuc, C.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S837 - S837
  • [8] Meta-analysis of propylthiouracil for alcoholic liver disease - a Cochrane Hepato-Biliary Group Review
    Rambaldi, A
    Gluud, C
    LIVER, 2001, 21 (06): : 398 - 404
  • [9] Proposed diagnostic criteria for acute-on-chronic liver failure in Japan
    Mochida, Satoshi
    Nakayama, Nobuaki
    Ido, Akio
    Inoue, Kazuaki
    Genda, Takuya
    Takikawa, Yasuhiro
    Sakaida, Isao
    Terai, Shuji
    Yokosuka, Osamu
    Shimizu, Masahito
    Takikawa, Hajime
    HEPATOLOGY RESEARCH, 2018, 48 (04) : 219 - 224
  • [10] Cochrane Hepato-Biliary Group Protocol - Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis
    Rambaldi, A
    Gluud, C
    LIVER, 2000, 20 (03): : 262 - 266